Suchergebnisse - "Doleżal-Ołtarzewska, Katarzyna"

PubPharm (27)

1

Effects of Recombinant Human Growth Hormone Treatment, Depending on the Therapy Start in Different Nutritional Phases in Paediatric Patients with Prader-Willi Syndrome : A Polish Multicentre Study

enthalten in: Journal of clinical medicine | 2021

von Lecka-Ambroziak, A. | Wysocka-Mincewicz, M. | Doleżal-Ołtarzewska, K. | +14

2

Correlation of Genotype and Perinatal Period, Time of Diagnosis and Anthropometric Data before Commencement of Recombinant Human Growth Hormone Treatment in Polish Patients with Prader-Willi Syndrome

enthalten in: Diagnostics (Basel, Switzerland) | 2021

von Lecka-Ambroziak, A. | Wysocka-Mincewicz, M. | Doleżal-Ołtarzewska, K. | +13

3

Cerebral salt wasting in a postoperative period

enthalten in: Neuro endocrinology letters | 2014

von Janus, D. | Wojcik, M. | Dolezal-Oltarzewska, K. | +3

4

Cerebral salt wasting in a postoperative period

enthalten in: Neuro-endocrinology letters | 2014

von Januś, D. | Ẃojcik, M. | Dolezal-Ołtarzewska, K. | +2

5

A decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescents

enthalten in: The journal of pediatric endocrinology and metabolism | 2012

von Wojcik, M. | Janus, D. | Dolezal-Oltarzewska, K. | +5

6

FGF23 contributes to insulin sensitivity in obese adolescents - preliminary results

enthalten in: Clinical endocrinology | 2012

von Wojcik, M. | Dolezal-Oltarzewska, K. | Janus, D. | +3

7

A decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescents

enthalten in: The journal of pediatric endocrinology and metabolism | 2012

von Wojcik, M. | Janus, D. | Dolezal-Oltarzewska, K. | +5

8

A decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescents

enthalten in: The journal of pediatric endocrinology and metabolism | 2012

von Wojcik, M. | Janus, D. | Dolezal-Oltarzewska, K. | +5

9

A decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescents

enthalten in: The journal of pediatric endocrinology and metabolism | 2012

von Wojcik, M. | Janus, D. | Dolezal-Oltarzewska, K. | +5

10

FGF23 contributes to insulin sensitivity in obese adolescents – preliminary results

enthalten in: Clinical endocrinology | 2012

von Wojcik, M. | Dolezal‐Oltarzewska, K. | Janus, D. | +3